Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

Table 1

Inclusion and exclusion criteria.

Inclusion criteria	Exclusion criteria
(1) Age range: 18–75 years	(1) Age <18 or >75 years
(2) HCC diagnosed according to EASL standards	(2) No pathology or image evidence
(3) Child–Pugh grade A or B	(3) Child–Pugh grade C
(4) HCC in BCLC stage C	(4) Patients with complete occlusion of the main portal vein
(5) ECOG score ≤2	(5) Patients with moderate or severe ascites
(6) The expected survival time >3 months	(6) Patients with serious comorbidities
	(7) The expected survival time ≤3 months
	(8) Patients who received other therapies during this study

EASL, European Association for the Study of the Liver; ECOG, Eastern Cooperative Oncology Group; HCC, hepatocellular carcinoma.